SermorelinLumivive Wellness GLP-1 Program
Sermorelin
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), corresponding to the GHRH (1-29) fragment. It is studied in laboratory research for its interaction with GHRH-receptor signaling and the secretagogue regulation of growth hormone release from the pituitary. In research settings, Sermorelin is studied as a GHRH analog in models of the somatotropic (GH/IGF-1) axis, endocrine signaling, and metabolic regulation. Unlike direct growth hormone, GHRH analogs are studied for their action on endogenous GH-secretory signaling pathways, making Sermorelin a common subject of endocrine and metabolic peptide research. Key Research Highlights Studied as a GHRH analog for endogenous growth-hormone secretagogue signaling Investigated for GHRH-receptor interaction and somatotropic-axis research Examined in models of metabolic and endocrine regulation Studied in research on cellular-repair and tissue-signaling pathways A frequent subject of endocrine and metabolic peptide research Product Specifications Form: Lyophilized powder Vial Size: 10 mg Purity: ≥98% (HPLC tested) Storage: Store dry at 2-8°C. After reconstitution, refrigerate and use within 20 days. For Research Use Only. Not for human consumption.
Research use only
Direct-purchase vials from Lumivive Wellness are supplied strictly for laboratory and research purposes only and are not for human consumption. These compounds are not FDA-approved drugs and are not intended to diagnose, treat, cure, or prevent any disease. For a clinical prescription route, book a telehealth visit with our independent licensed partner.
$70.00
View cart and checkout